The man who'd prove all studies wrong

On the phone, John Ioannidis comes across much more cheerfully than you might expect from a man who has made a career out of pointing out the more questionable aspects of others' research endeavors.

Written byStuart Blackman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On the phone, John Ioannidis comes across much more cheerfully than you might expect from a man who has made a career out of pointing out the more questionable aspects of others' research endeavors. But perhaps he has good reasons to be cheerful.

First, his is a career that has been shaped to a large extent by a long and rewarding romance. Second, if refuting erroneous hypotheses and data is a yardstick of scientific success, Ioannidis is arguably a particularly successful scientist – though that might depend on whether his recent claim that most research findings are false is not itself proved wrong.

Ioannidis has previously identified statistical and experimental design problems based on high-throughput techniques such as microarrays that can lead to gene-disease predictions being no better than chance (see the Dec. 20, 2004, issue of The Scientist). He has also followed the fate of research findings to quantify ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies